These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 23280513)

  • 1. Circulating mRNA for epidermal growth factor-like domain 7 (EGFL7) in maternal blood and early intrauterine growth restriction. A preliminary analysis.
    Zanello M; DeSanctis P; Pula G; Zucchini C; Pittalis MC; Rizzo N; Farina A
    Prenat Diagn; 2013 Feb; 33(2):168-72. PubMed ID: 23280513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls.
    Farina A; Sekizawa A; Purwosunu Y; Rizzo N; Banzola I; Concu M; Morano D; Giommi F; Bevini M; Mabrook M; Carinci P; Okai T
    Prenat Diagn; 2006 Dec; 26(12):1115-20. PubMed ID: 16952198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia.
    Papadopoulou E; Sifakis S; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
    Growth Horm IGF Res; 2006; 16(5-6):290-6. PubMed ID: 16996762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental gene expression patterns of epidermal growth factor in intrauterine growth restriction.
    Rab A; Szentpéteri I; Kornya L; Börzsönyi B; Demendi C; Joó JG
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):96-9. PubMed ID: 23810060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced circulating retinol and non-esterified fatty acids in pregnancies complicated with intrauterine growth restriction.
    Ortega-Senovilla H; Alvino G; Taricco E; Cetin I; Herrera E
    Clin Sci (Lond); 2009 Nov; 118(5):351-8. PubMed ID: 19656084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free fetal DNA is not increased before 20 weeks in intrauterine growth restriction or pre-eclampsia.
    Crowley A; Martin C; Fitzpatrick P; Sheils O; O'Herlihy C; O'Leary JJ; Byrne BM
    Prenat Diagn; 2007 Feb; 27(2):174-9. PubMed ID: 17191257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation.
    Wathén KA; Ylikorkala O; Andersson S; Alfthan H; Stenman UH; Vuorela P
    Acta Obstet Gynecol Scand; 2009; 88(5):593-8. PubMed ID: 19308751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factors for low birth weight and intrauterine growth retardation in Santiago, Chile].
    Vega J; Sáez G; Smith M; Agurto M; Morris NM
    Rev Med Chil; 1993 Oct; 121(10):1210-9. PubMed ID: 8191127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating EGFL7 distinguishes between IUGR and PE: an observational case-control study.
    Massimiani M; Salvi S; Tiralongo GM; Moresi S; Stuhlmann H; Valensise H; Lanzone A; Campagnolo L
    Sci Rep; 2021 Sep; 11(1):17919. PubMed ID: 34504270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal quantification of uterine artery blood volume flow changes during gestation in pregnancies complicated by intrauterine growth restriction.
    Konje JC; Howarth ES; Kaufmann P; Taylor DJ
    BJOG; 2003 Mar; 110(3):301-5. PubMed ID: 12628272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation.
    Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
    J Matern Fetal Neonatal Med; 2007 Jul; 20(7):527-32. PubMed ID: 17674266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum activin A levels in association with intrauterine fetal growth restriction.
    Wallace EM; Schneider-Kolsky ME; Edwards A; Baker L; Jenkin G
    BJOG; 2003 Mar; 110(3):306-10. PubMed ID: 12628273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression patterns of the 11β-hydroxysteroid dehydrogenase 2 enzyme in human placenta from intrauterine growth restriction: the role of impaired feto-maternal glucocorticoid metabolism.
    Börzsönyi B; Demendi C; Pajor A; Rigó J; Marosi K; Agota A; Nagy ZB; Joó JG
    Eur J Obstet Gynecol Reprod Biol; 2012 Mar; 161(1):12-7. PubMed ID: 22239940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal maternal cardiac function and morphology in pregnancies complicated by intrauterine fetal growth restriction.
    Vasapollo B; Valensise H; Novelli GP; Larciprete G; Di Pierro G; Altomare F; Casalino B; Galante A; Arduini D
    Ultrasound Obstet Gynecol; 2002 Nov; 20(5):452-7. PubMed ID: 12423481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating osteoprotegerin and sRANKL concentrations in the perinatal period at term. The impact of intrauterine growth restriction.
    Briana DD; Boutsikou M; Baka S; Hassiakos D; Gourgiotis D; Malamitsi-Puchner A
    Neonatology; 2009; 96(2):132-6. PubMed ID: 19365143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated with intrauterine growth restriction.
    Borras D; Perales-Puchalt A; Ruiz Sacedón N; Perales A
    J Obstet Gynaecol; 2014 Apr; 34(3):218-20. PubMed ID: 24484391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of oxidative stress in intrauterine growth restriction.
    Biri A; Bozkurt N; Turp A; Kavutcu M; Himmetoglu O; Durak I
    Gynecol Obstet Invest; 2007; 64(4):187-92. PubMed ID: 17664879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrauterine growth restriction is associated with alterations in placental lipoprotein receptors and maternal lipoprotein composition.
    Wadsack C; Tabano S; Maier A; Hiden U; Alvino G; Cozzi V; Hüttinger M; Schneider WJ; Lang U; Cetin I; Desoye G
    Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E476-84. PubMed ID: 17003234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR.
    Cozzi V; Garlanda C; Nebuloni M; Maina V; Martinelli A; Calabrese S; Cetin I
    Placenta; 2012 Dec; 33(12):1039-44. PubMed ID: 23062219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of maternal plasma HTRA1 level in preeclampsia complicated by IUGR.
    Marzioni D; Lorenzi T; Altobelli E; Giannubilo SR; Paolinelli F; Tersigni C; Crescimanno C; Monsurrò V; Tranquilli AL; Di Simone N; Castellucci M
    Placenta; 2012 Dec; 33(12):1036-8. PubMed ID: 23083999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.